Cargando…

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

Background Although indomethacin and ibuprofen are the standard treatments for hemodynamically significant patent ductus arteriosus (hsPDA), they are associated with renal impairment and gastrointestinal complications. Paracetamol for hsPDA closure does not provoke a peripheral vasoconstrictive eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oshima, Ayumi, Matsumura, Shun, Iwatani, Ayaka, Morita, Machiko, Fujinuma, Sumie, Motojima, Yukiko, Tanaka, Kosuke, Masutani, Satoshi, Kabe, Kazuhiko, Ueda, Keiko, Namba, Fumihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical Publishers 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056395/ https://www.ncbi.nlm.nih.gov/pubmed/32140292 http://dx.doi.org/10.1055/s-0040-1702945

Ejemplares similares

Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
por: Matsumura, Shun, et al.
Publicado: (2017)

Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure
por: Roofthooft, Daniëlla W. E., et al.
Publicado: (2015)

Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017)

Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates – A randomized controlled trial
por: Meena, Vasudha, et al.
Publicado: (2020)

iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants
por: Namba, Fumihiko, et al.
Publicado: (2023)

Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts
por: Kushnir, Alla, et al.
Publicado: (2011)

Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017)

Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial
por: Dang, Dan, et al.
Publicado: (2013)

Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
por: Dani, Carlo, et al.
Publicado: (2020)

Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants
por: Lu, Jinmiao, et al.
Publicado: (2019)

Comparison of Gastrointestinal Complications of Paracetamol and Ibuprofen in the Management of Infants with Patent Ductus Arteriosus: A Randomized Clinical Trial Study
por: Shahmirzadi, Gohar, et al.
Publicado: (2021)

Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
por: Terrin, Gianluca, et al.
Publicado: (2014)

Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
por: Yoo, Hani, et al.
Publicado: (2017)

Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial
por: Yang, Bo, et al.
Publicado: (2016)

Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020)

The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance
por: Murphy, Claire, et al.
Publicado: (2022)

Ibuprofen for Ductus Arteriosus Months after Birth
por: Frauenfelder, Odile, et al.
Publicado: (2016)

Indomethacin induced ductus arteriosus closure in midgestation fetus
por: Beaute, Jeanette I., et al.
Publicado: (2018)

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
por: García-Robles, Ana, et al.
Publicado: (2020)

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)‐ibuprofen
por: Padrini, Roberto, et al.
Publicado: (2021)

Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus
por: Bagheri, Mohammad Mehdi, et al.
Publicado: (2016)

Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants
por: Kim, Chae Young, et al.
Publicado: (2022)

Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial
por: Dani, Carlo, et al.
Publicado: (2016)

The efficacy and safety of oral paracetamol versus oral ibuprofen for patent ductus arteriosus closure in preterm neonates – A systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2020)

Corrigendum: Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
por: García-Robles, Ana, et al.
Publicado: (2022)

A Case of a Full-Term Infant With Symptomatic Patent Ductus Arteriosus Successfully Closed With Indomethacin Treatment: Consideration of Mechanism for Ductus Arteriosus Closure
por: Tanabe, Junya, et al.
Publicado: (2019)

High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates
por: Pourarian, Shahnaz, et al.
Publicado: (2015)

Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants
por: Ding, Yanjie, et al.
Publicado: (2018)

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
por: Flint, Robert B., et al.
Publicado: (2018)

The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants
por: Engbers, Aline G. J., et al.
Publicado: (2022)

Change in Blood Pressure and Pulse Pressure in Preterm Infants After Treatment of Patent Ductus Arteriosus With Indomethacin
por: Han, Ui Joung, et al.
Publicado: (2011)

Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
por: Ghaderian, Mehdi, et al.
Publicado: (2019)

Case of Patent Ductus Arteriosus
por: Harrington, Archibald W.
Publicado: (1914)

The Wide Patent Ductus Arteriosus
por: Aitken, G. J.
Publicado: (1955)

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
por: Jannatdoust, Abdollah, et al.
Publicado: (2014)

Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus
por: Mydam, Janardhan, et al.
Publicado: (2019)

Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
por: Ghaderian, Mehdi, et al.
Publicado: (2019)

Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants
por: Hsu, Kai-Hsiang, et al.
Publicado: (2019)

Patent Ductus Arteriosus Device Embolization
por: Iqbal, K, et al.
Publicado: (2011)

Pharmacological closure of the patent ductus arteriosus
por: Mehta, SK, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_f9vc35bq5malma4b3pihhl9q5f